Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (31-40 of 358) with videos related to

Pageof 36
Sort By:
Expert Review of Cardiovascular Therapy|June 24, 2008
Is it over for ezetimibe?Jennifer G Robinson, Michael Davidson
Dialogues in Clinical Neuroscience|July 24, 2020
Do DSM classifications help or hinder
drug development?
Michael Davidson, Cristian Gabos-Grecu
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
Cognitive impairment and psychosis in schizophrenia: independent or linked conditions?Abraham Reichenberg, Eva Velthorst, Michael Davidson
Journal of Clinical Lipidology|May 17, 2017
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteersElliot Offman, Michael Davidson, Catarina Nilsson
Melanoma Management|September 8, 2018
High-risk cutaneous melanoma follow-up: time for more intensive surveillance?Michael Davidson, Paul Lorigan, James Larkin
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 16, 2017
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy VolunteersElliot Offman, Michael Davidson, Catarina Nilsson
Schizophrenia Research|June 21, 2005
Comments on risk for schizophreniaMark Weiser, Michael Davidson, Shlomo Noy
Harefuah|April 7, 2004
[Placebo-controlled trials in schizophrenia]Yuval Melamed, Michael Davidson, Avi Bleich
International Journal of Circumpolar Health|February 18, 2004
Cardiovascular disease among Alaska Natives: a review of the literatureCatherine Schumacher, Michael Davidson, Gretchen Ehrsam
Dialogues in Clinical Neuroscience|August 3, 2005
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosisMichael Davidson, Asaf Caspi, Shlomo Noy
Pageof 36

Showing results (31-40 of 358) with videos related to

Sort By:
Pageof 36
Expert Review of Cardiovascular Therapy|June 24, 2008
Is it over for ezetimibe?Jennifer G Robinson, Michael Davidson
Dialogues in Clinical Neuroscience|July 24, 2020
Do DSM classifications help or hinder
drug development?
Michael Davidson, Cristian Gabos-Grecu
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
Cognitive impairment and psychosis in schizophrenia: independent or linked conditions?Abraham Reichenberg, Eva Velthorst, Michael Davidson
Journal of Clinical Lipidology|May 17, 2017
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteersElliot Offman, Michael Davidson, Catarina Nilsson
Melanoma Management|September 8, 2018
High-risk cutaneous melanoma follow-up: time for more intensive surveillance?Michael Davidson, Paul Lorigan, James Larkin
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 16, 2017
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy VolunteersElliot Offman, Michael Davidson, Catarina Nilsson
Schizophrenia Research|June 21, 2005
Comments on risk for schizophreniaMark Weiser, Michael Davidson, Shlomo Noy
Harefuah|April 7, 2004
[Placebo-controlled trials in schizophrenia]Yuval Melamed, Michael Davidson, Avi Bleich
International Journal of Circumpolar Health|February 18, 2004
Cardiovascular disease among Alaska Natives: a review of the literatureCatherine Schumacher, Michael Davidson, Gretchen Ehrsam
Dialogues in Clinical Neuroscience|August 3, 2005
The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosisMichael Davidson, Asaf Caspi, Shlomo Noy
Pageof 36